Results 111 to 120 of about 463,492 (156)

Exploring the therapeutic landscape of pulmonary hypertension associated with interstitial lung disease, with a focus on idiopathic pulmonary fibrosis: a narrative review. [PDF]

Front Pharmacol
Reccardini N, Da Re B, Mondini L, Salton F, Confalonieri M, Confalonieri P, Hughes M, Monteleone G, Ruaro B.   +8 more
europepmc   +1 more source

Mechanisms Underlying the Biphasic Effects of Hydrogen Sulfide in Rat Intrapulmonary Arteries. [PDF]

Biomedicines
Tunaitytė A, Alan E, Aleknavičius A, Abramavičius S, Simonsen U, Stankevičius E.   +5 more
europepmc   +1 more source

Coronary microvascular dysfunction in HFpEF: pathophysiologic mechanisms, diagnosis, treatments, and the amplifying potential of sepsis. [PDF]

Front Med (Lausanne)
Chattha S, Kapadia K, Lynch D, McWhorter Y.   +3 more
europepmc   +1 more source

The Therapeutic Efficacy of Drugs Targeting the NO-sGC-cGMP Pathway in Treatment of Patients With Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review. [PDF]

Pulm Circ
Alqarni AA, Aljedani RH, Aldhahir AM, Alasimi AH, AlGarni AA, Alqahtani JS, Alghamdi SM, Siraj RA, Mengash A, Alwafi H.   +9 more
europepmc   +1 more source

Pitfalls of Therapies Targeting the Nitric Oxide Signaling Pathway in Heart Failure With Preserved Ejection Fraction. [PDF]

J Cardiovasc Pharmacol
Loeb SA, Tharp DL, Zawieja SD, Pal S, Abbate A, Isakson BE.   +5 more
europepmc   +1 more source

Vericiguat in Elderly Patients with Heart Failure and Reduced Ejection Fraction: Clinical Perspectives from Pathophysiology to Implementation. [PDF]

J Clin Med
Rao CM, Lucà F, Ceravolo R, Gulizia MM, Gelsomino S, Ingianni N, Vatrano M, Chiappetta D, Scarpino T, Geraci G, Oliva F, Nardi F, Grimaldi M, Parrini I.   +13 more
europepmc   +1 more source

Randomized controlled trial of vericiguat in patients with coronary microvascular dysfunction causing stable chest pain (V-COM): study protocol for a randomized control trial. [PDF]

J Cardiovasc Magn Reson
Lo CK, Ip NH, Sin TH, Ho SY, Wong CK, Tam FC, Lam SC, Yiu KH, Sze MS, Lam TT, Chiu ACH, Li KK, Un KC, Yu EY, Chan EK, Lee KK, Ching S, Lee DP, Wong CY, Chan HL, Chan NY, Leung CY, Ng MY.   +22 more
europepmc   +1 more source

The NO Pathway as a Target in Patients with Stable and Advanced Heart Failure: An Additional Arrow in Our Quiver! [PDF]

Biomolecules
D'Elia S, Gentile C, Solimene A, Franzese R, Luisi E, Caiazzo A, Marotta L, Covino S, Natale F, Loffredo FS, Golino P, Cimmino G.   +11 more
europepmc   +1 more source

Pulmonary hypertension associated with interstitial lung disease: a state-of-the-art review. [PDF]

Eur Respir J
Raghu G, Sahay S, Price LC, Weatherald J, Rayner SG, Behr J, Boucly A, Das M, McLaughlin V, Rahaghi F, Rutland C, Ryu JH, Saggar R, Humbert M.   +13 more
europepmc   +1 more source

Vericiguat: A New Horizon for Heart Failure Treatment. [PDF]

Rev Cardiovasc Med
Carbonaro C, Bocchino PP, Bertello E, Griffith Brookles C, Angelini F, Gallone G, Pidello S, Feneziani A, Raineri C, De Ferrari GM.   +9 more
europepmc   +1 more source